This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
We are now in the heart of the second-quarter earnings reporting season, with perhaps the busiest week of the season on deck. Most of the companies in the S&P 500 will be reporting this week and will most definitely set a direction for the markets. With this season also comes high expectations, as the Nasdaq and S&P 500 have risen recently to near all-time highs. This earnings season will be driven by some of the biggest companies in the United States, but they have to hit their targets first if the markets want to keep up their momentum.
HAL F UAA MA PYPL HOG SYF UA MAT HAS GM.WS.A GM.WS.B GM.WS.C TRI SBUX GM GM.WSB
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
YUM AROC TCAP HYRE ABT CRM BXS BHC CHFC RGA CSCO TBIO UXIN CAH PKD MS HSY GWP SNAP NCMI FOX JCOM HOMB AMC GILD MNLO UTX SYF MDT CYS EXPE ACB GWPH EMHTF JNJ ALV VZ APHQF VNE LMT FB RF.PRB OLED RF.PRA STIM WFC.PRL NFLX WFC.PRJ BAX EHC SKX BAC WFC.PRT ZION OKE.WI WFC.PRR WFC.PRQ WFC.PRP WFC.PRO CYS.PRA CL WFC.PRN CYS.PRB FPBK TCCB OKE WFC.PRY TCCA INTC WFC.PRX WFC.PRW AGS WFC.PRV CBS UL WYNN EVER MA GSK FNSR TCDA UA FFKT NTGN HAS FNKO SBUX CAKE APTV TXN TBQBF XOM ACBFF TWX UAA MS.PRE RF RDI MS.PRF MS.PRG IMAX CNK MS.PRA GTES AMZN TWTR HMNY TWO EBAY BBT ARMO BAC CMA EYEN CRON BV TCC MDLZ CMG PFS MS.PRI BJ GOOGL MS.PRK LVS QCOM FOXA PFE LOVE WFCNP HAL PM HRB WWW GPC PYPL PAGS DLPH MCS PFG TWMJF RDIB AMCX WEED ACN DIS MCD ABT WFC WFC.WS QRVO MJN F SLDB BRY CMCSA K CGC SNPS EMH T MRK CVX FTSV SNE LITE MEDFF PZZA TILE
Both species, a new study conducted by researchers at the University of Minnesota Medical School has found, express profound regret over how much time is spent waiting for something to happen. The study examined the behaviors of humans and mice before each was given an option to wait and receive reward (food for mice, videos for humans) and then after making the commitment while waiting to receive it.
AMZN SBUX WMT
The first Starbucks signing store in the U.S. will be opening its doors to customers later this year.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Novartis (NVS) and Goldman Sachs (GS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
WFCNP HD NTRSP KMI.WS WFC.PRL WAFDW WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ KMI.PRA WFC.PRP KMI NTRS WFC.PRO GM.WS.A WFC.PRN GM.WS.B GM.WS.C WAFD GM WFC.PRY WFC.PRX KMR CVB WFC.PRW WFC.PRV WFC WFC.WS ROST NVS MSFT SBUX GM.WSB KMRFZ
Assuming that free cash flow growth increased to 20% per year starting from 2021, then the five-year upside for this company still looks favourable.
U.S. companies are collecting record amounts of cash in their coffers, and many can’t think of anything better to do with it than buy back their stock. Here’s a better idea: Hand out some of those shares to rank-and-file employees.
Starbucks Corp. (NASDAQ: SBUX) recently announced that it will be opening its first “Signing Store” in the United States, specifically in Washington D.C. This new store will be manned by a team of deaf Starbucks partners (employees), and allies led an effort to launch this unique store model. The store is expected to open in early October.
Imagine, Canadian coffee on the streets of Beijing. Imagine 1,500 stores competing directly with Starbucks Corp. (NASDAQ:SBUX) and its planned 5,000 store network. Imagine Chinese going around wearing beanies and talking about hockey.
BRK.A KHC SBUX QSR MCD QSR.WI ABEV
Starbucks Corp. SBUX, +0.06% said Thursday that it will open a cafe in October that caters to the needs of the deaf and hard of hearing. All of the associates in the new Washington D.C. store, about 20 to 25, will be fluent in American Sign Language (ASL). The idea for the store came from the Starbucks Signing Store in Kuala Lumpur, Malaysia, which opened in 2016 with nine deaf workers. Starbucks shares are down 0.
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp, a partnership that illustrates how Microsoft’s chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE
So when Thyssenkrupp North America needed help predicting when to service its lifts, it turned to Microsoft Corp , a partnership that illustrates how Microsoft's chief executive, Satya Nadella, has leveraged the cloud to grow its own business.
KR CVX MSFT SBUX ADBE
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to SBUX / Starbucks Corp. on message board site Silicon Investor.
|Starbucks (SBUX)||Coffee Shop|
as of ET